Haemocompatibility of paediatric membrane oxygenators with heparin-coated surfaces

被引:28
作者
Wendel, HP [1 ]
Scheule, AM [1 ]
Eckstein, FS [1 ]
Ziemer, G [1 ]
机构
[1] Univ Tubingen, Dept Surg, Div Thorac Cardiac & Vasc Surg, D-72076 Tubingen, Germany
来源
PERFUSION-UK | 1999年 / 14卷 / 01期
关键词
D O I
10.1177/026765919901400104
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Extracorporeal circulation (ECC) in paediatric patients with heparin-coated oxygenation systems is rarely investigated. The objective of this study was to evaluate, preclinically, the haemocompatibility of paediatric membrane oxygenators with heparin-coated surfaces. We compared 16 paediatric membrane oxygenators (Minimax, Medtronic) in an in vitro heart-lung machine model with fresh human brood. Eight of these oxygenation systems had a covalent heparin coating (Carmeda bioactive surface). After 90 min simulated ECC, the heparin-coated systems showed significantly higher platelet count, lower platelet-factor 4 release, reduced contact activation (factor Xlla and kallikrein), and lower neutrophil elastase levels (p < 0.05), compared to the noncoated oxygenator group. More biocompatible materials for paediatric operations may ameliorate the various postperfusion syndromes arising from ECC procedures, particularly unspecific inflammation, hyperfibrinolysis and blood loss.
引用
收藏
页码:21 / 28
页数:8
相关论文
共 38 条
[1]   Release of proinflammatory cytokines during pediatric cardiopulmonary bypass: Heparin-bonded versus nonbonded oxygenators [J].
Ashraf, S ;
Tian, Y ;
Cowan, D ;
Entress, A ;
Martin, PG ;
Watterson, KG .
ANNALS OF THORACIC SURGERY, 1997, 64 (06) :1790-1794
[2]   BLOOD CONSERVATION TECHNIQUES AND PLATELET-FUNCTION IN CARDIAC-SURGERY [J].
BOLDT, J ;
ZICKMANN, B ;
CZEKE, A ;
HEROLD, C ;
DAPPER, F ;
HEMPELMANN, G .
ANESTHESIOLOGY, 1991, 75 (03) :426-432
[3]   DECREASED BLOOD-LOSS AFTER CARDIOPULMONARY BYPASS USING HEPARIN-COATED CIRCUIT AND 50-PERCENT REDUCTION OF HEPARIN DOSE [J].
BOROWIEC, J ;
THELIN, S ;
BAGGE, L ;
HULTMAN, J ;
HANSSON, HE .
SCANDINAVIAN JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 1992, 26 (03) :177-185
[4]  
BOROWIEC J, 1992, J THORAC CARDIOV SUR, V104, P642
[5]   Circulating cytokines and granulocyte-derived enzymes during complex heart surgery - A clinical study with special reference to heparin-coating of cardiopulmonary bypass circuits [J].
Borowiec, JW ;
Hagman, L ;
Totterman, TH ;
Pekna, M ;
Venge, P ;
Thelin, S .
SCANDINAVIAN JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 1995, 29 (04) :167-174
[6]  
CARVALHO AC, 1988, J LAB CLIN MED, V112, P270
[7]   HEMOSTATIC COMPLICATIONS OF CARDIOPULMONARY BYPASS [J].
COLMAN, RW .
AMERICAN JOURNAL OF HEMATOLOGY, 1995, 48 (04) :267-272
[8]   INITIATION OF BLOOD-COAGULATION AT ARTIFICIAL SURFACES [J].
COLMAN, RW ;
SCOTT, CF ;
SCHMAIER, AH ;
WACHTFOGEL, YT ;
PIXLEY, RA ;
EDMUNDS, LH .
ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1987, 516 :253-267
[9]   Contact system: A vascular biology modulator with anticoagulant, Profibrinolytic, antiadhesive, and proinflammatory attributes [J].
Colman, RW ;
Schmaier, AH .
BLOOD, 1997, 90 (10) :3819-3843
[10]  
DELNIDO PJ, 1994, CIRCULATION, V90, P66